Global NSAIDs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global NSAIDs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
NSAIDs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NSAIDs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Back Pain Treatment and Osteoarthritis Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NSAIDs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, NSAIDs key manufacturers include Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company and Kopran, etc. Bayer, Novacap, Abbott are top 3 players and held % sales share in total in 2022.
NSAIDs can be divided into Aspirin, Ibuprofen, Naproxen and Nabumetone, etc. Aspirin is the mainstream product in the market, accounting for % sales share globally in 2022.
NSAIDs is widely used in various fields, such as Back Pain Treatment, Osteoarthritis Treatment and Other Disease Treatment,, etc. Back Pain Treatment provides greatest supports to the NSAIDs industry development. In 2022, global % sales of NSAIDs went into Back Pain Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NSAIDs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the NSAIDs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of NSAIDs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the NSAIDs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of NSAIDs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, NSAIDs introduction, etc. NSAIDs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of NSAIDs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for NSAIDs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, NSAIDs key manufacturers include Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company and Kopran, etc. Bayer, Novacap, Abbott are top 3 players and held % sales share in total in 2022.
NSAIDs can be divided into Aspirin, Ibuprofen, Naproxen and Nabumetone, etc. Aspirin is the mainstream product in the market, accounting for % sales share globally in 2022.
NSAIDs is widely used in various fields, such as Back Pain Treatment, Osteoarthritis Treatment and Other Disease Treatment,, etc. Back Pain Treatment provides greatest supports to the NSAIDs industry development. In 2022, global % sales of NSAIDs went into Back Pain Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NSAIDs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the NSAIDs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of NSAIDs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the NSAIDs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of NSAIDs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, NSAIDs introduction, etc. NSAIDs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of NSAIDs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.